Zhangzhang Lan

Dr. Zhangzhang Lan

School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XWXiaoming Wei
Xiaoming Wei
XJXiangchun Ju
Xiangchun Ju
XYXin Yi
Xin Yi
QZQian Zhu
Qian Zhu
NQNing Qu
Ning Qu
JHJian Huang
Jian Huang
Identification of gene variants plays an important role in research on and diagnosis of genetic diseases. A combination of enrichment of targeted genes and next-generation sequencing (targeted DNA-HiSeq) results in both high efficiency and low cost for targeted sequencing of genes of interest. To identify mutations associated with genetic diseases, we designed an array-based gene chip to capture all of the exons of 193 genes involved in 103 genetic diseases. To evaluate this technology, we selected 7 samples from seven patients with six different genetic diseases resulting from six disease-causing genes and 100 samples from normal human adults as controls. The data obtained showed that on average, 99.14% of 3,382 exons with more than 30-fold coverage were successfully detected using Targeted DNA-HiSeq technology, and we found six known variants in four disease-causing genes and two novel mutations in two other disease-causing genes (the STS gene for XLI and the FBN1 gene for MFS) as well as one exon deletion mutation in the DMD gene. These results were confirmed in their entirety using either the Sanger sequencing method or real-time PCR. Targeted DNA-HiSeq combines next-generation sequencing with the capture of sequences from a relevant subset of high-interest genes. This method was tested by capturing sequences from a DNA library through hybridization to oligonucleotide probes specific for genetic disorder-related genes and was found to show high selectivity, improve the detection of mutations, enabling the discovery of novel variants, and provide additional indel data. Thus, targeted DNA-HiSeq can be used to analyze the gene variant profiles of monogenic diseases with high sensitivity, fidelity, throughput and speed.

7 December 2021 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
HLHemi Luan
Hemi Luan
WGWanjian Gu
Wanjian Gu
HLHua Li
Hua Li
ZWZi Wang
Zi Wang
LLLu Lu
Lu Lu
WZWenyong Zhang
Wenyong Zhang
Background: Diagnosing seronegative rheumatoid arthritis (RA) can be challenging due to complex diagnostic criteria. We sought to discover diagnostic biomarkers for seronegative RA cases by studying metabolomic and lipidomic changes in RA patient serum. Methods: We performed comprehensive metabolomic and lipidomic profiling in serum of 225 RA patients and 100 normal controls. These samples were divided into a discovery set (n = 243) and a validation set (n = 82). A machine-learning-based multivariate classification model was constructed using distinctive metabolites and lipids signals. Results: Twenty-six metabolites and lipids were identified from the discovery cohort to construct a RA diagnosis model. The model was subsequently tested on a validation set and achieved accuracy of 90.2%, with sensitivity of 89.7% and specificity of 90.6%. Both seropositive and seronegative patients were identified using this model. A co-occurrence network using serum omics profiles was built and parsed into six modules, showing significant association between the inflammation and immune activity markers and aberrant metabolism of energy metabolism, lipids metabolism and amino acid metabolism. Acyl carnitines (20:3), aspartyl-phenylalanine, pipecolic acid, phosphatidylethanolamine PE (18:1) and lysophosphatidylethanolamine LPE (20:3) were positively correlated with the RA disease activity, while histidine and phosphatidic acid PA (28:0) were negatively correlated with the RA disease activity. Conclusions: A panel of 26 serum markers were selected from omics profiles to build a machine-learning-based prediction model that could aid in diagnosing seronegative RA patients. Potential markers were also identified in stratifying RA cases based on disease activity.

12 June 2013 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
XWXiaoming Wei
Xiaoming Wei
YDYi Dai
Yi Dai
PYPing Yu
Ping Yu
NQNing Qu
Ning Qu
ZLZhangzhang Lan
Zhangzhang Lan
XYXin Yi
Xin Yi
Duchenne and Becker muscular dystrophies (DMD/BMD) are the most commonly inherited neuromuscular disease. However, accurate and convenient molecular diagnosis cannot be achieved easily because of the enormous size of the dystrophin gene and complex causative mutation spectrum. Such traditional methods as multiplex ligation-dependent probe amplification plus Sanger sequencing require multiple steps to fulfill the diagnosis of DMD/BMD. Here, we introduce a new single-step method for the genetic analysis of DMD patients and female carriers in real clinical settings and demonstrate the validation of its accuracy. A total of 89 patients, 18 female carriers and 245 non-DMD patients were evaluated using our targeted NGS approaches. Compared with traditional methods, our new method yielded 99.99% specificity and 98.96% sensitivity for copy number variations detection and 100% accuracy for the identification of single-nucleotide variation mutations. Additionally, this method is able to detect partial deletions/duplications, thus offering precise personal DMD gene information for gene therapy. We detected novel partial deletions of exons in nine samples for which the breakpoints were located within exonic regions. The results proved that our new method is suitable for routine clinical practice, with shorter turnaround time, higher accuracy, and better insight into comprehensive genetic information (detailed breakpoints) for ensuing gene therapy.

1 March 2013 in Gene
Verified
Journal Article
Closed access
XQXiao-ping Qi
Xiao-ping Qi
ZDZhen-Fang Du
Zhen-Fang Du
JMJu-Ming Ma
Ju-Ming Ma
XCXiao-Ling Chen
Xiao-Ling Chen
QZQing Zhang
Qing Zhang
XZXian-Ning Zhang
Xian-Ning Zhang

16 November 2017 in Prenatal Diagnosis
Verified
Journal Article
Closed access
PDF file
FCFang Chen
Fang Chen
PLPing Liu
Ping Liu
YGYing Gu
Ying Gu
ZZZhu Zhu
Zhu Zhu
ANAmulya Nanisetti
Amulya Nanisetti
XXXun Xu
Xun Xu

1 August 2014 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
YYYanqin You
Yanqin You
YSYan Sun
Yan Sun
XLXuchao Li
Xuchao Li
YLYali Li
Yali Li
XWXiaoming Wei
Xiaoming Wei
ZGZhiying Gao
Zhiying Gao